Patients with ulcerative colitis [UC] require rapid and complete relief of symptoms, particularly stool frequency and rectal bleeding. The aim of this study was to determine time to symptom resolution in patients with UC during induction treatment with multimatrix mesalazine, and the proportion of patients remaining symptom-free and in endoscopic remission after 12 months of maintenance.

中文翻译：

---

多基质美沙拉嗪治疗溃疡性结肠炎症状解决时间：汇总分析。

溃疡性结肠炎 [UC] 患者需要快速和完全缓解症状，尤其是大便频率和直肠出血。本研究的目的是确定多基质美沙拉嗪诱导治疗期间 UC 患者症状消退的时间，以及维持 12 个月后保持无症状和内镜缓解的患者比例。